Most cited papers from Patrys (Germany)
What are the most cited papers from Patrys (Germany)?
The most cited paper from Patrys (Germany) is "A new tumor-specific variant of GRP78 as target for antibody-based therapy" (Nicole Rauschert, Stephanie Brändlein, Elisabeth Holzinger et al., 2008), with 130 citations. Next come "GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6" (101) and "Expression and glycoengineering of functionally active heteromultimeric IgM in plants" (85).
Showing 10 of 10 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | A new tumor-specific variant of GRP78 as target for antibody-based therapy Nicole Rauschert, Stephanie Brändlein, Elisabeth Holzinger et al. · Laboratory Investigation | 11 Feb 2008 | 130 |
| 2 | GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 Leo Rasche, Johannes Duell, Inês C. Castro et al. · Haematologica | 30 Jan 2015 | 101 |
| 3 | Expression and glycoengineering of functionally active heteromultimeric IgM in plants Andreas Loos, Clemens Grünwald‐Gruber, Friedrich Altmann et al. · Proceedings of the National Academy of Sciences | 31 Mar 2014 | 85 |
| 4 | The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78 Leo Rasche, Johannes Duell, Charlotte Morgner et al. · PLoS ONE | 7 May 2013 | 68 |
| 5 | High level expression of functional human IgMs in human PER.C6® cells Anna Tchoudakova, Frank Hensel, Alec Murillo et al. · mAbs | Mar 2009 | 63 |
| 6 | Early development of PAT-SM6 for the treatment of melanoma Frank Hensel, Miriam Eckstein, Andreas Rosenwald et al. · Melanoma Research | 30 May 2013 | 38 |
| 7 | Chromatographic behavior of IgM:DNA complexes Pete Gagnon, Frank Hensel, Soon Lee et al. · Journal of Chromatography A | 24 Dec 2010 | 29 |
| 8 | Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1 Frank Hensel, W. Timmermann, Burkhard H.A. von Rahden et al. · Oncology Reports | 20 Jan 2014 | 24 |
| 9 | The Anti-Cancer IgM Monoclonal Antibody PAT-SM6 Binds with High Avidity to the Unfolded Protein Response Regulator GRP78 Zachary Rosenes, Terrence D. Mulhern, Danny M. Hatters et al. · PLoS ONE | 19 Sep 2012 | 21 |
| 10 | Simultaneous Binding of the Anti-Cancer IgM Monoclonal Antibody PAT-SM6 to Low Density Lipoproteins and GRP78 Zachary Rosenes, Yee-Foong Mok, Shuo Yang et al. · PLoS ONE | 19 Apr 2013 | 7 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.